|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"kuo sheng chu"
Showing items 11-20 of 91 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2016 |
A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models
|
Huang, Shiu-Wen; Kuo, Heng-Lan; Hsu, Ming-Tsung; Tseng, Yufeng Jane; Lin, Shu-Wha; Kuo, Sheng-Chu; Peng, Hui-Chin; Lien, Jin-Cherng; Huang, Tur-Fu; 林淑華; 彭惠琴; 黃德富 |
| 國立臺灣大學 |
2016 |
DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling
|
Huang, Shiu-Wen; Lien, Jin-Cherng; Kuo, Sheng-Chu; Huang, Tur-Fu; 黃德富 |
| 國立成功大學 |
2015-06-25 |
Novel pyrazole derivatives effectively inhibit osteoclastogenesis, a potential target for treating osteoporosis
|
洪欣儀; Hung, Hsin-Yi; Kuo, Ting-Hao;Lin, Tzu-Hung;Yang, Rong-Sen;Kuo, Sheng-Chu;Fu, Wen-Mei |
| 國立成功大學 |
2015-06 |
The newly synthesized 2-arylnaphthyridin-4-one, CSC-3436, induces apoptosis of non-small cell lung cancer cells by inhibiting tubulin dynamics and activating CDK1
|
Chang, Ling-Chu; Yu, Yung-Luen; Liu, Chin-Yu; Cheng, Yung-Yi; Chou, Ruey-Hwang; Hsieh, Min-Tsang; Lin, Hui-Yi; Hung, Hsin-Yi; Huang, Li-Jiau; Wu, Yang-Chang; Kuo, Sheng-Chu |
| 國立成功大學 |
2015-01-27 |
Design and synthesis of new 2-arylnaphthyridin-4-ones as potent antitumor agents targeting tumorigenic cell lines
|
Liu, Chin-Yu; Cheng, Yung-Yi; Chang, Ling-Chu; Huang, Li-Jiau; Chou, Li-Chen; Huang, Chi-Hung; Tsai, Meng-Tung; Liao, Chih-Chang; Hsu, Mei-Hua; Lin, Hui-Yi; Wu, Tian-Shung; Wen, Yen-Fang; Zhao, Yu; Kuo, Sheng-Chu; Lee, Kuo-Hsiung |
| 中山醫學大學 |
2015 |
Mitotic arrest induced in human DU145 prostate cancer cells in response to KHC-4 treatment
|
Shen, Cheng-Huang; Lin, Tien-Huang; Hsieh, You-Liang; Shen, Chia-Yao; Kuo, Sheng-Chu; Wu, Hsi-Chin; Chien, Wen-Shin; Hsieh, Dennis Jine-Yuan; Wen, Su-Ying; Ting, Wei-Jen; Yao, Chun-Hsu; Huang, Chih-Yang |
| 國立臺灣大學 |
2015 |
Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis
|
Kuo, Ting-Hao; Lin, Tzu-Hung; Yang, Rong-Sen; Kuo, Sheng-Chu; Fu, Wen-Mei; Hung, Hsin-Yi; 楊榮森; 符文美 |
| 國立臺灣大學 |
2015 |
Novel curcumin analogs to overcome EGFR-TKI lung adenocarcinoma drug resistance and reduce EGFR-TKI-induced GI adverse effects
|
Wada, Koji; Lee, Jen-Yi; Hung, Hsin-Yi; Shi, Qian; Lin, Li; Zhao, Yu; Goto, Masuo; Yang, Pan-Chyr; Kuo, Sheng-Chu; Chen, Hui-Wen; Lee, Kuo-Hsiung; 楊泮池; 陳惠文 |
| 國立交通大學 |
2014-12-08T15:07:23Z |
Synthesis and Preclinical Evaluations of 2-(2-Fluorophenyl)-6,7-methylenedioxyquinolin-4-one Monosodium Phosphate (CHM-1-P-Na) as a Potent Antitumor Agent
|
Chou, Li-Chen; Chen, Chien-Ting; Lee, Jang-Chang; Way, Tzong-Der; Huang, Chi-Hung; Huang, Shih-Ming; Teng, Che-Ming; Yamori, Takao; Wu, Tian-Shung; Sun, Chung-Ming; Chien, Du-Shieng; Qian, Keduo; Morris-Natschke, Susan L.; Lee, Kuo-Hsiung; Huang, Li-Jiau; Kuo, Sheng-Chu |
| 國立成功大學 |
2014-11 |
MJ-66 induces malignant glioma cells G2/M phase arrest and mitotic catastrophe through regulation of cyclin B1/Cdk1 complexE
|
Liu, Wei-Ting; Chen, Ching; Lu, I-Chen; Kuo, Sheng-Chu; Lee, Kuo-Hsiung; Chen, Tai-Lin; Song, Ta-Shu; Lu, Yi-Liang; Gean, Po-Wu; Hour, Mann-Jen |
Showing items 11-20 of 91 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
